Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: inside layer (24), coating (68), liner (5)

Steroid therapy for brain tumours - patient information

Description: Information about steroid therapy for brain tumours.
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Steroid-therapy-for-brain-tumours-494-PIL.pdf

Paclitaxel (21 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (21day) Regimen • Breast Cancer – Paclitaxel (21day) Indication • Treatment of locally advanced or metastatic breast cancer that
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-21-day.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen • CLL – VR Rituximab Venetoclax (high
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Paclitaxel (7 day)

Description: Chemotherapy Protocol BREAST CANCER PACLITAXEL (7 day) Regimen • Breast Cancer – Paclitaxel (7 day) Indication • Treatment of locally advanced or metastatic breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Paclitaxel-7-day.pdf

Paclitaxel (7 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER PACLITAXEL (7 day) Regimen • Ovary – Paclitaxel (7 day) Indication • Second or subsequent line treatment of platinum refractory
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Paclitaxel-7-day.pdf

Liposomal doxorubicin

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER LIPOSOMAL DOXORUBICIN (Caelyx) Please note this protocol is based on information for the use of the Caelyx
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Liposomaldoxorubicin.pdf

Cisplatin-Fluorouracil

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CISPLATIN and FLUOROURACIL Regimen • Gastrointestinal Cancer (upper) – Cisplatin and Fluorouracil Indication • First line therapy of advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Cisplatin-Fluorouracil.pdf

Capecitabine-Mitomycin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-Mitomycin Indication • Second / third line therapy of metastatic/advanced colorectal cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Institutional information_2021_final

Description: Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document
Url: /Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2021-final.pdf

Procedure for using seca scales with length measure

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system for the writing
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-using-seca-scales-with-length-measure.pdf

261 to 270 of 743

Previous … 25 26 27 28 29 … Next